CJC-1295 + Ipamorelin – Research Peptide Complex

CJC-1295 + Ipamorelin – Research Peptide Complex
Class: GHRH / Ghrelin mimetic synergistic blend  
Form: Lyophilized powder
Purity: ≥ 99% (HPLC verified individual components)
Storage (dry): Room temperature, away from light
Storage (reconstituted): Refrigerate 2–8°C
Solvent compatibility: Bacteriostatic Water (preferred)  
CJC-1295 (without DAC) and Ipamorelin is a widely studied research combination that leverages two distinct pathways to stimulate the endogenous release of growth hormone. CJC-1295 + Ipamorelin acts as a Growth Hormone Releasing Hormone (GHRH) analog, while Ipamorelin serves as a selective Growth Hormone Secretagogue (GHS) and ghrelin receptor agonist. This dual-action blend is utilized in laboratory models to investigate hormone secretion patterns and their effects on metabolic regulation.  
Key Research Focus Areas
Endogenous Hormone Secretion: Analysis of the synergistic pulse frequency and amplitude of growth hormone in research models.
Metabolic Rate & Lipid Turnover: Investigation of the blend’s influence on adipocyte metabolism and fatty acid oxidation.
Cellular Recovery & Hypertrophy: Study of its impact on muscle protein synthesis and recovery from physical stress simulations.
Sleep Architecture & Circadian Rhythm: Researching how these peptides interact with deep-wave sleep cycles in pre-clinical studies.  
Bone Mineral Density Signaling: Evaluation of its role in promoting osteoblast activity and long-term skeletal integrity.
Format Options
10 mg (5mg + 5mg) lyophilized powder
Optional BAC solvent available separately
Important Notice
All products are sold for laboratory research use